{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:06:25Z","timestamp":1790629585978,"version":"4.1.0"},"reference-count":58,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,25]]},"DOI":"10.18632\/oncotarget.16179","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T16:57:38Z","timestamp":1489510658000},"page":"48820-48831","source":"Crossref","is-referenced-by-count":77,"title":["EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy"],"prefix":"10.18632","volume":"8","author":[{"given":"Issam","family":"Chebouti","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Essen, 45147 Essen, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kasimir-Bauer","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Essen, 45147 Essen, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Buderath","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Essen, 45147 Essen, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01307 Dresden, Germany"},{"name":"National Center for Tumor Diseases (NCT), Partner Site Dresden, 69120 Heidelberg, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Hauch","sequence":"additional","affiliation":[{"name":"QIAGEN, 40724 Hilden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kimmig","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Essen, 45147 Essen, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Dominik","family":"Kuhlmann","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01307 Dresden, Germany"},{"name":"National Center for Tumor Diseases (NCT), Partner Site Dresden, 69120 Heidelberg, Germany"},{"name":"German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/cncr.11349","article-title":"Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","article-title":"2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","volume":"16","author":"Fujiwara","year":"2005","journal-title":"Ann Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)","volume":"115","author":"Pfisterer","year":"2009","journal-title":"Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2007.02.026","article-title":"Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)","volume":"106","author":"Du Bois","year":"2007","journal-title":"Gynecol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)","volume":"17","author":"du Bois","year":"2010","journal-title":"Annals of Surgical Oncology"},{"key":"6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.seminoncol.2008.12.003","article-title":"Management of recurrent ovarian carcinoma: current status and future directions","volume":"36","author":"Schilder","year":"2009","journal-title":"Seminars in Oncology"},{"key":"7","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Liang","year":"2011","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(14)70228-1","article-title":"Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial","volume":"15","author":"Spencer","year":"2014","journal-title":"Lancet Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ygyno.2014.03.016","article-title":"Circulating and disseminated tumor cells in ovarian cancer: a systematic review","volume":"133","author":"Diaz-Padilla","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","article-title":"Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy","volume":"21","author":"Wimberger","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance\u2014a study of the OVCAD consortium","volume":"128","author":"Zeillinger","year":"2013","journal-title":"Gynecol Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2007.07.073","article-title":"Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer","volume":"107","author":"Kasimir-Bauer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Pearl","year":"2009","journal-title":"Gynecol Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"e0130873","DOI":"10.1371\/journal.pone.0130873","article-title":"Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis","volume":"10","author":"Shen","year":"2015","journal-title":"PLoS One"},{"key":"15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","article-title":"ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance","volume":"60","author":"Kasimir-Bauer","year":"2014","journal-title":"Clin Chem"},{"key":"16","doi-asserted-by":"publisher","first-page":"26454","DOI":"10.18632\/oncotarget.8524","article-title":"Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?","volume":"7","author":"Kasimir-Bauer","year":"2016","journal-title":"Oncotarget"},{"key":"17","article-title":"Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel","author":"Neubauer","year":"2016","journal-title":"Mol Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"41677","DOI":"10.18632\/oncotarget.9528","article-title":"Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment","volume":"7","author":"Kasimir-Bauer","year":"2016","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"publisher","first-page":"48625","DOI":"10.18632\/oncotarget.8015","article-title":"Evaluation and consequences of heterogeneity in the circulating tumor cell compartment","volume":"7","author":"Van Laere","year":"2016","journal-title":"Oncotarget"},{"key":"20","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2333","article-title":"Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients","volume":"11","author":"Kasimir-Bauer","year":"2009","journal-title":"Breast Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Sequist","year":"2013","journal-title":"Science"},{"key":"22","article-title":"The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells","author":"Yin","year":"2014","journal-title":"J Clin Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1158\/1078-0432.CCR-05-0687","article-title":"Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma","volume":"11","author":"Su","year":"2005","journal-title":"Clin Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1091\/mbc.e08-10-1076","article-title":"ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells","volume":"20","author":"Henry","year":"2009","journal-title":"Mol Biol Cell"},{"key":"25","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1128\/MCB.01164-08","article-title":"A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis","volume":"29","author":"Peeper","year":"2009","journal-title":"Mol Cell Biol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1242\/jcs.069443","article-title":"Visualizing extravasation dynamics of metastatic tumor cells","volume":"123","author":"Klemke","year":"2010","journal-title":"J Cell Sci"},{"key":"27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","article-title":"Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1","volume":"22","author":"Nieto","year":"2012","journal-title":"Cancer Cell"},{"key":"28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4161\/cbt.11.8.15274","article-title":"EMT: a new vision of hypoxia promoting cancer progression","volume":"11","author":"Liang","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Weinberg","year":"2009","journal-title":"J Clin Invest"},{"key":"30","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1158\/1078-0432.CCR-04-2142","article-title":"Frequent mutation of the PIK3CA gene in ovarian and breast cancers","volume":"11","author":"Boyd","year":"2005","journal-title":"Clin Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Cantley","year":"2006","journal-title":"Nat Rev Genet"},{"key":"32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Zhao","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","article-title":"A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition","volume":"9","author":"Lu","year":"2015","journal-title":"Cell Adhesion & Migration"},{"key":"34","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1007\/s13277-014-2163-y","article-title":"Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer","volume":"35","author":"Fu","year":"2014","journal-title":"Tumour Biology"},{"key":"35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156800910791190175","article-title":"Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer","volume":"10","author":"Quinn","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"36","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/jcb.23199","article-title":"Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile","volume":"112","author":"Ahmed","year":"2011","journal-title":"J Cell Biochem"},{"key":"37","first-page":"33","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Reich","year":"2012","journal-title":"Front Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1373\/clinchem.2010.154328","article-title":"Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges","volume":"57","author":"Markou","year":"2011","journal-title":"Clin Chem"},{"key":"39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201303698","article-title":"Biology, detection, and clinical implications of circulating tumor cells","volume":"7","author":"Pantel","year":"2015","journal-title":"EMBO Mol Med"},{"key":"40","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1200\/JCO.2008.18.0497","article-title":"Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer","volume":"27","author":"Mavroudis","year":"2009","journal-title":"J Clin Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1158\/0008-5472.CAN-12-4140","article-title":"Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing","volume":"73","author":"Sill","year":"2013","journal-title":"Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1200\/JCO.2005.04.5948","article-title":"Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients","volume":"24","author":"Lianidou","year":"2006","journal-title":"J Clin Oncol"},{"key":"43","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/ijc.26111","article-title":"Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select\/Detect versus Veridex CellSearch system","volume":"130","author":"Cristofanilli","year":"2012","journal-title":"Int J Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr3099","article-title":"Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells","volume":"14","author":"Fehm","year":"2012","journal-title":"Breast Cancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Stanger","year":"2012","journal-title":"Cell"},{"key":"46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2164-9-246","article-title":"Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate","volume":"9","author":"Liu","year":"2008","journal-title":"BMC Genomics"},{"key":"47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Gerstein","year":"2003","journal-title":"Genome Biol"},{"key":"48","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1534\/genetics.106.065862","article-title":"Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: a quantitative analysis","volume":"174","author":"Zhang","year":"2006","journal-title":"Genetics"},{"key":"49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10555-012-9370-z","article-title":"Plasticity of disseminating cancer cells in patients with epithelial malignancies","volume":"31","author":"Pantel","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"50","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/sj.onc.1205389","article-title":"Cooperative role of E-cadherin and sialyl-Lewis X\/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma","volume":"21","author":"Barsky","year":"2002","journal-title":"Oncogene"},{"key":"51","doi-asserted-by":"publisher","first-page":"55069","DOI":"10.18632\/oncotarget.10396","article-title":"Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study","volume":"7","author":"Farace","year":"2016","journal-title":"Oncotarget"},{"key":"52","article-title":"Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high CTC counts","author":"Stebbing","year":"2016","journal-title":"Clin Cancer Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Hadfield","year":"2013","journal-title":"Nature"},{"key":"54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13058-016-0679-3","article-title":"Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy","volume":"18","author":"Hoffmann","year":"2016","journal-title":"Breast Cancer Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/cbt.8.1.7209","article-title":"PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients","volume":"8","author":"Kupryjanczyk","year":"2009","journal-title":"Cancer Bio Ther"},{"key":"56","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.18632\/oncotarget.2428","article-title":"TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis","volume":"5","author":"Yin","year":"2014","journal-title":"Oncotarget"},{"key":"57","first-page":"262","article-title":"Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells","volume":"6","author":"Li","year":"2015","journal-title":"Stem Cell Res"},{"key":"58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","article-title":"Histopathologic grading of ovarian carcinoma: a review and proposal","volume":"19","author":"Silverberg","year":"2000","journal-title":"Int J Gynecol Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T20:39:34Z","timestamp":1589143174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":58,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,7,25]]}},"alternative-id":["16179","28415744"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16179","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}